California Setting Stage for Crackdown on Dubious Stem Cell Clinics
By David Jensen,
California Stem Cell Report
| 12. 09. 2018
The California stem cell agency, state regulators and lawmakers are taking aim at the more than 100 dubious, unregulated "stem cell" clinics now operating in the Golden State.
The goal is to curb clinics that are using what they describe as stem cells in treatments costing thousands of dollars but that have not been tested scientifically.Lawsuits have been filed around the country alleging damage to patients that includes blindness.
Art Torres, vice chairman of the state stem cell agency, is now working with lawmakers to formulate legislation that is expected to be introduced by the end of January.
At the same time, the State Medical Board, which licenses and regulates physicians, has chartered a task force to look into the the growing business.
Earlier this fall, Torres told the governing board of the California Institute for Regenerative Medicine (CIRM), as the agency is formally known, that he was engaged with Assemblyman Kevin Mullin, D-San Mateo, on a bill.
Torres, a former state lawmaker, said the legislation is expected to involve certification of clinics by a...
Related Articles
By Lucy Tu, The Atlantic | 07.11.2025
Donald Trump—who is, by his own accounting, “the fertilization president” and “the father of IVF”—wants to help Americans reproduce. During his 2024 campaign, he promised that the government or insurance companies would cover the cost of in vitro fertilization. In...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Ben Fidler and Ned Pagliarulo, Biopharma Dive | 07.21.2025
One month ago, a 51-year-old man treated in a clinical trial with an experimental gene therapy became dangerously sick. The developer of that treatment, Sarepta Therapeutics, informed the Food and Drug Administration his case could be life-threatening.
The man died...
By Pat Duggins, Alabama Public Radio | 06.27.2025
PAT DUGGINS-- If I were to say, ‘man, have you seen the price of eggs these days?’ You're probably thinking, Oh, he's talking about inflation and the price of groceries and how it became an issue in the presidential race...
